Clinical Trials Logo

Filter by:
NCT ID: NCT03400943 Terminated - Uterine Fibroids Clinical Trials

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Start date: January 17, 2018
Phase: Phase 3
Study type: Interventional

The primary objective of this study was to show superiority in the treatment of HMB of vilaprisan in subjects with uterine fibroids compared to placebo. The secondary objectives of this study were to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.

NCT ID: NCT03400852 Terminated - Clinical trials for Muscular Dystrophy, Duchenne

A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy

BRAVE
Start date: July 27, 2018
Phase: Phase 2
Study type: Interventional

This is a multicenter, double blind, placebo controlled, multiple dose study to examine the safety and efficacy of MNK-1411 in male subjects 4 to 8 years of age (inclusive) with Duchenne Muscular Dystrophy (DMD).

NCT ID: NCT03400540 Completed - Clinical trials for Pelvic Floor Muscle Weakness

What is the Best Verbal Instruction for Contraction the Pelvic Floor Muscles?

Start date: January 22, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to T to compare the effectiveness of producing a pelvic floor muscle contraction by different verbal instruction. Pelvic floor muscle contraction will be measured displacement of the pelvic floor when imaged on ultrasound.

NCT ID: NCT03400150 Completed - Prostate Cancer Clinical Trials

ProSpace™ Balloon System Pivotal Study BP-007

Start date: January 3, 2018
Phase: N/A
Study type: Interventional

The ProSpace™ System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the ProSpace System to reduce the radiation dose delivered to the anterior rectum. ProSpace is a balloon composed of a biodegradable material that maintains that space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.

NCT ID: NCT03399266 Recruiting - Clinical trials for Prelabor Rupture of Membranes

Balloon Induction of Labor in PROM for TOLAC

BILROM-TOLAC
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

A prospective randomized controlled trial to evaluate the safety and efficacy of labor induction with a double balloon catheter (Atad Ripener Device) in women desiring TOLAC (trial of labor after cesarean) with PROM (pre labor rupture of membranes).

NCT ID: NCT03399097 Withdrawn - Obesity Clinical Trials

Characterizing the Intestinal Hormonal Secretion in Non-obese, Obese and Non-obese Patients After Bariatric Surgery

Start date: December 2018
Phase:
Study type: Observational

The enteroendocrine system is composed from different cells along the different parts of the gastrointestinal tract, secreting diverse hormones and bariatric surgery alters intestinal hormone secretion, affecting glycemic control and weight. The aim of the study is to characterize the composition and secretory profile of enteroendocrine cells in the obese, non-obese and non-obese post bariatric surgery.

NCT ID: NCT03398928 Completed - Delirium in Old Age Clinical Trials

Delirium Treatment With Acupuncture in Internal Medicine Departments

Start date: January 14, 2018
Phase: N/A
Study type: Interventional

Delirium frequently occurs in hospitalized older people, and treatment options are limited. Acupuncture has been shown to reduce agitation in the setting of dementia. The investigators will test the hypothesis that it may also assist in treating delirium.

NCT ID: NCT03398837 Terminated - Clinical trials for Diffuse Cutaneous Systemic Sclerosis

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

RESOLVE-1
Start date: December 18, 2017
Phase: Phase 3
Study type: Interventional

This is a Phase 3 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of diffuse cutaneous systemic sclerosis (SSc). Approximately 354 subjects will be enrolled in this study at about 60 sites in North America, Europe, Australia, and Asia. The planned duration of treatment with study drug is 52 weeks.

NCT ID: NCT03398668 Completed - Migraine Clinical Trials

Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

Start date: February 22, 2018
Phase: N/A
Study type: Interventional

This study will evaluate the clinical performance and safety of a self administered abortive treatment for migraine headache using combined occipital and supraorbital transcutaneous nerve stimulator (Neurolief device, Relievion™).

NCT ID: NCT03398655 Completed - Clinical trials for Recurrent Platinum Resistant Ovarian Cancer

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

OVAL
Start date: December 19, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant Ovarian Cancer.